Avonova Bidco AB (publ) (“Avonova”) delivered a strong Q2 2025.

Group revenues came in at NOK 446 million (0.3% YoY growth), while ARR ended at NOK 421 million (31.8% YoY growth).

Profitability continued to increase during the quarter and EBITDA* ended at NOK 14,8 million (NOK -20,5 million Q2 2024).
Proforma adjusted EBITDA** (financing EBITDA) LTM Q2 2025 was NOK 94.4 million.

Net Interest Bearing Debt (NIBD) ended at NOK 323.9 million. 

The complete Q2 2025 report will be released on 29. August 2025, at 09:00 CEST

*defined as Operating profit/loss minus Depreciation of tangible and intangible assets
** for covenant calculation Proforma Adj EBITDA definition will be used according Avonova BidCo Bond Term Sheet

About Us
Avonova is Nordic’s leading provider of occupational health services and is the only Nordic occupational health services provider with a fully integrated hybrid digital/physical delivery model.

Avonova offers a comprehensive range of services to promote well-being and reduce absences, among employees of companies and institutions of all sizes and in all industries. It is leading in preventive evidence based occupational health services in highest impact areas, such as presenteeism, vaccination, and drug testing and rehab.

Avonova has its main offices in Larvik, Norway and Stockholm, Sweden and delivers its services digitally and from 166 locations in Norway and Sweden, by about 1 100 employees – mainly physicians, psychiatrists, nurses, and workplace engineers. For more information, visit www.avonova.se/no/fi.

Attachments
Trading update Q2 2025

Läs mer på MFN